Page 2 - Les Meilleurs doctors pour votre Immunothérapie pour le cancer de la prostate - TOP 40 des médecins

Le Professeur Cicin apporte plus de 25 ans d'expérience en oncologie, avec une expertise spécifique en immunothérapie pour le cancer de la prostate, à l'Hôpital Liv Topkapı de l'Université İstinye.

• Spécialisé en oncologie médicale grâce à une bourse de perfectionnement (fellowship) obtenue à l'Université de Trakya
• Actuellement Professeur d'oncologie médicale à l'Université de Trakya
• Vaste expérience dans des contextes oncologiques tant cliniques qu'académiques

Le Professeur Associé Atakan Topcu est spécialisé en thérapies ciblées et en immunothérapie pour le cancer de la prostate à l'Hôpital de District Medipol Acibadem.

• A publié plus de 50 articles scientifiques en oncologie
• Membre de la Société Européenne d'Oncologie Médicale (ESMO)
• Formation spécialisée (Fellowship) en oncologie médicale à l'Université Bezmialem Vakıf
• Expertise en oncologie gériatrique et en malnutrition liée au cancer

Professeur Associé d'Oncologie Médicale à l'Hôpital Liv de l'Université İstinye Topkapı, spécialisé en immunothérapie pour le cancer de la prostate.

• Membre de l'American Society of Clinical Oncology (ASCO) depuis 2018
• A publié de multiples articles évalués par des pairs sur les résultats du traitement du cancer
• Coordinateur de l'éducation pour la Sous-branche d'Oncologie Médicale à l'Hôpital Municipal Prof. Dr. Cemil Taşcıoğlu

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Nir Kleinmann, MD, directs the Endourology and Kidney Stones Unit at Sheba Medical Center. He is an expert in minimally invasive urology and urologic oncology. His focus is the kidney and upper urinary tract. He was named among Israel’s Best Doctors for 2025–2026 by Forbes and ResultMed.

He is a pioneer of kidney‑sparing laser surgery. He uses a dual‑laser system with neodymium and holmium for complex tumors. His expertise includes UTUC, kidney and prostate cancer, kidney stones, and BPH.

His research includes the OLYMPUS trial on chemoablation for UTUC. He has more than 60 publications.

He is an Israeli board‑certified urologist. He is a Fellow of the American Endourology Society and a member of the Israeli Urological Association and the EAU. He completed fellowships in Endourology and Minimally Invasive Surgery at Thomas Jefferson University. He also completed a fellowship in Kidney Cancer Research at McMaster University.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Dr. Osama Abdel Mohimen Mohamed is Head of the Hematology Unit at Shefaa Al Orman Oncology Hospitals. He is also a consultant in medical oncology and hematology at Shefa El Orman Hospital (NGO), Luxor (2019–present).

He diagnoses and treats acute and chronic leukemia, lymphoma, myeloma, myelodysplastic syndromes, and myeloproliferative neoplasms. He also manages complications of solid tumors.

Background: He served at the National Cancer Institute, Cairo University, as a medical oncology resident, then demonstrator and assistant lecturer (2008–2022). Earlier, he was a house officer (2006–2007). He also held specialist roles at Al Salam International, Al Molalmen, and BAHEYA Oncology Center (NGO).

Memberships: ESMO (2008–present). American Society of Bone Marrow Transplantation (2009). ASH (2010).

Dr. Maha Yahia is a medical oncologist and hemato-oncologist. She provides assessment, diagnosis, and treatment planning. Her treatments include chemotherapy, targeted therapy, and immunotherapy. She cares for patients with breast, genitourinary, gynecologic, thoracic, gastrointestinal, and rare cancers.

Education: M.B.B.Ch, Kasr El-Aini, Cairo University (1997–2003). Master in Hemato-oncology, National Cancer Institute, Cairo University (2008). Doctoral Degree in Hemato-oncology, National Cancer Institute, Cairo University (2015).

Experience: Resident in Medical Oncology, Maadi AFMC (2005–2010). Visitor Resident, NCI Cairo (2008–2009). Consultant Assistant, Prof. Hussein Khaled Clinic (2010–2017). Specialist, International Medical Center (2011–2012), Wadi El Nile Hospital (2013–2014), and Maadi AFMC (2011–2018). Head, Clinical Research Support Team, Maadi AFMC (2016–2018). Major (2014–2016) and Lt. Colonel Doctor (2016–2018), Egyptian Armed Forces. Lecturer of Clinical Research, AFCM (2019–2021).

Dr. Emad Shash, M.B.B.Ch, MSc, M.D., is a medical oncologist. He is the Medical Director of the Breast Comprehensive Cancer Hospital at NCI. He leads the Medical Oncology Department and is the Breast Program Director at Shifaa Al Orman Cancer Hospital in Luxor. His clinical focus includes breast, gynecologic, genitourinary, thoracic, gastrointestinal, and rare cancers. He specializes in systemic therapy, including chemotherapy, targeted therapy, and immunotherapy.

He served as coordinating research physician and medical lead at the EORTC from 2011 to 2015. Since 2008, he has contributed to more than 70 international oncology trials as a coordinator, sub-investigator, principal investigator, and sponsor medical monitor. Credentials include M.B.B.Ch (2004), MSc (2010), MD (2015), and the EORTC Certificate of Excellence (2015). He also holds a Diploma in Hospital Quality Management & Patient Safety (JCI/57357, 2017). He is a Fellow of the EIO. He is a member of ESMO (panel voting), ESGO, and ASCO (IAC), and serves on the ECRIN board.

Dr. Mariam Mohammed Hussein Abu Zeid is a clinical oncologist. She treats solid tumors and hematologic cancers. She earned her MBBCh from Ain Shams University in 2007 (Excellent). She completed a Master’s in Clinical Oncology and Nuclear Medicine in 2011 (Very Good). She received a Ph.D. in 2018 and an ESMO Certificate in 2015.

She leads and monitors clinical trials. Her work includes data collection and analysis. She administers chemotherapy and manages treatment toxicities. She also plans care with multidisciplinary teams. Her experience includes Ain Shams University Hospitals (2009–2012), the International Medical Center (2012–2014), and Wadi El Nile Hospital (2015–2019). Her roles covered diagnosis and staging, supportive care, quality improvement, and screening. She educates patients and families about the diagnosis, treatment options, and palliative care.

Spécialisé en radiothérapie – Le Dr Sridhar P.S. apporte une expertise approfondie dans le traitement du cancer de la prostate au HCG Manavata Cancer Centre.

• Diplomate of National Board en radiothérapie
• Membre de l'Association of Radiation Oncology of India
• Membre du Bangalore Oncology Group
• Spécialiste en neuro-oncologie et en oncologie par hyperthermie

Plus de 50 000 chirurgies oncologiques réalisées en 19 ans – Le Dr Nagarkar est spécialisé en oncologie chirurgicale, avec un accent sur l'amélioration de la qualité de vie des patients.

• Formé au Tata Memorial Hospital et au Royal College of Surgeons d'Édimbourg
• A mené plus de 200 essais cliniques en phases 1 à 3
• Spécialisé en oncologie chirurgicale mammaire et thoracique
• Professeur pour le DNB Superspecialty Surgical Oncology et la chirurgie mammaire

Présentation de recherches sur le cancer de l'estomac au symposium de l'American Society of Clinical Oncology – Le Dr Valame est spécialisé dans les thérapies ciblées pour le cancer de la prostate.

• DNB en oncologie médicale de l'hôpital Indraprastha Apollo
• Registrar en oncologie médicale au Jawaharlal Nehru Cancer Hospital
• Conférencier à l'International Winter School of Oncology
• Expertise dans les bases moléculaires du cancer

Plus de 10 000 chirurgies majeures réalisées sur 10 ans, spécialisé en chirurgies oncologiques mini-invasives avec d'excellents résultats.

• Formation par bourse de perfectionnement en oncologie chirurgicale au Tata Medical Centre, Kolkata
• Accent particulier sur les chirurgies du cancer gastro-intestinal
• Co-investigateur principal dans plusieurs projets de recherche originaux
• Publié dans des revues nationales et internationales

Le Dr Ahmer Arif Shaikh est spécialisé en oncologie chirurgicale, se concentrant sur le cancer de la bouche et la rééducation fonctionnelle, au HCG Manavata Cancer Centre.

• 3 ans d'expérience en oncologie chirurgicale
• Expertise en préservation d'organes et rééducation fonctionnelle
• Compétent dans les chirurgies maxillofaciales majeures et des chirurgies de la tête et du cou
• Formation de type « Fellowship » en oncologie chirurgicale de la tête et du cou
• Chercheur actif avec de multiples publications

Le Dr Shruti Kate est spécialisée en immunothérapie pour les cancers avancés, y compris le cancer de la prostate, avec une formation au Tata Memorial Hospital – un centre de cancérologie de premier plan en Inde.

• DM en oncologie médicale du Tata Memorial Hospital
• Expertise dans les cancers du poumon, du sein et génito-urinaires
• Membre de l'ASCO, de l'ESMO et d'autres sociétés d'oncologie de premier plan
• Recherches présentées à la Conférence mondiale sur le cancer du poumon

Le Dr Borde a réalisé plus de 30 000 TEP et traité plus de 1 000 patients atteints de cancer de la thyroïde au HCG Manavata Cancer Centre.

• 12 ans d'expérience en médecine nucléaire
• Spécialisé dans les thérapies à l'iode radioactif et au Lu-177 RN
• Recherches publiées dans des revues médicales
• Expert en TEP-TDM et cardiologie nucléaire